Physician profile
Gregory P Midis
NPI 1033226162
$1,923.36
in general payments reported to CMS, 2019-2025
13 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $114 · 2021: $420 · 2022: $622 · 2023: $64.05 · 2024: $198 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $1,008.37 | 2019-2025 | Vistaseal, Ethicon, Stratafix |
| Intuitive Surgical, INC. | $582.69 | 2019-2022 | |
| Angiodynamics, INC. | $66.82 | 2019-2023 | Nanoknife |
| W. L. Gore & Associates, INC. | $49.11 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Merck Sharp & Dohme LLC | $45.24 | 2022 | |
| Stryker Corporation | $40.33 | 2023-2024 | Spy-Phi System, Eikon Lt Adapt Smoke Evacuation, Eikon |
| Medtronic, INC. | $26.70 | 2024 | Ligasure |
| Takeda Pharmaceuticals U.S.A., INC. | $22.93 | 2023 | Gattex |
| Ambu INC. | $22.68 | 2022 | |
| Boston Scientific Corporation | $18.13 | 2021 | |
| Daiichi Sankyo INC. | $16.79 | 2022 | |
| Conmed Corporation | $12.93 | 2021 | |
| Merit Medical Systems INC | $10.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Midis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.